SCHEMBL5899671

SCHEMBL5899671

Cc1cc(C)cc(S(=O)(=O)NC(C)(C)C(=O)c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.44
KAT6A Q92794 3/20 0.42
LMNA P02545 2/20 0.41
THRB P10828 1/20 0.41
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
METAP2 P50579 1/20 0.40
CES1 P23141 2/20 0.40
FFAR4 Q5NUL3 1/20 0.40
NAT1 P18440 1/20 0.38
IDH1 O75874 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPT P10636 1/20 0.37
SRC P12931 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899419 0.87 ALDH1A1 (0.49) LMNAALDH1A1TP53TDP1KMT2A
SCHEMBL5899488 0.86 KAT6A (0.49) KAT6ACES1ALDH1A1MEN1KMT2A
SCHEMBL14676471 0.81 SLC1A3 (0.46) ACLYLMNATHRBSLC1A3SLC1A2
SCHEMBL5899700 0.81 HTT (0.44) LMNAALDH1A1TP53MEN1KMT2A
SCHEMBL5899417 0.81 ADAMTS4 (0.50) KAT6AMEN1KMT2AMAPT
SCHEMBL5899486 0.80 KAT6A (0.57) KAT6ALMNASLC1A3SLC1A2SLC1A1
SCHEMBL5899418 0.80 PFKFB3 (0.54) ACLYKAT6ALMNAMEN1KMT2A
SCHEMBL5899495 0.79 ALDH1A1 (0.50) LMNASLC1A2ALDH1A1MEN1KMT2A
SCHEMBL5899422 0.79 FLT1 (0.57) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL5899463 0.79 ITGA1 (0.49) KAT6AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 ACLY 1905/4885KAT6A 2440/4885LMNA 3336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.